The present disclosure relates to compositions, methods, and systems for selectively activating and/or expanding T cells for use in therapy. For example, the method may include contacting a population of T cells with an agent capable of binding an extracellular domain of a chimeric antigen receptor (CAR) that is expressed on the surface of the population of T cells.
